- Home
- HIND vs BOLT Comparison
HIND vs BOLT Comparison
Compare HIND & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIND
- BOLT
- Stock Information
- Founded
- HIND N/A
- BOLT 2015
- Country
- HIND United States
- BOLT United States
- Employees
- HIND N/A
- BOLT N/A
- Industry
- HIND
- BOLT Biotechnology: Pharmaceutical Preparations
- Sector
- HIND
- BOLT Health Care
- Exchange
- HIND Nasdaq
- BOLT Nasdaq
- Market Cap
- HIND 10.3M
- BOLT 11.5M
- IPO Year
- HIND 2016
- BOLT 2021
- Fundamental
- Price
- HIND $5.53
- BOLT $5.72
- Analyst Decision
- HIND
- BOLT Buy
- Analyst Count
- HIND 0
- BOLT 4
- Target Price
- HIND N/A
- BOLT $34.00
- AVG Volume (30 Days)
- HIND N/A
- BOLT 39.0K
- Earning Date
- HIND N/A
- BOLT 11-14-2025
- Dividend Yield
- HIND N/A
- BOLT N/A
- EPS Growth
- HIND N/A
- BOLT N/A
- EPS
- HIND N/A
- BOLT N/A
- Revenue
- HIND N/A
- BOLT $4,167,000.00
- Revenue This Year
- HIND N/A
- BOLT N/A
- Revenue Next Year
- HIND N/A
- BOLT N/A
- P/E Ratio
- HIND N/A
- BOLT N/A
- Revenue Growth
- HIND N/A
- BOLT N/A
- 52 Week Low
- HIND N/A
- BOLT $4.59
- 52 Week High
- HIND N/A
- BOLT $14.00
- Technical
- Relative Strength Index (RSI)
- HIND 46.05
- BOLT 49.91
- Support Level
- HIND $5.31
- BOLT $5.61
- Resistance Level
- HIND $5.70
- BOLT $6.35
- Average True Range (ATR)
- HIND 0.37
- BOLT 0.36
- MACD
- HIND 0.13
- BOLT -0.01
- Stochastic Oscillator
- HIND 64.57
- BOLT 17.05
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.